SWITCH OR ADD PEGYLATED-INTERFERON IN CHRONIC HEPATITIS B PATIENTS ON LONG TERM NUCLEOS(T)IDE THERAPY (SWAP TRIAL)
Phase of Trial: Phase IV
Latest Information Update: 25 Sep 2019
Price : $35 *
At a glance
- Drugs Peginterferon alfa-2b (Primary) ; Nucleoside reverse transcriptase inhibitors
- Indications Hepatitis B
- Focus Therapeutic Use
- Acronyms SWAP
- 14 Mar 2019 Status changed from recruiting to completed.
- 31 Aug 2018 Biomarkers information updated
- 23 Mar 2016 Elderly patient are also included now in the trial as per ClinicalTrials.gov record.